RAPT Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 01/23/2025 | 22.35 M | $35.32 M | 100.00% | 57.46% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 13.14 M | $20.75 M | 100.00% | 33.76% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 13.14 M | $19.75 M | 100.00% | 33.76% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 02/14/2025 | 12.50 M | $19.75 M | 100.00% | 32.13% |
| RTW INVESTMENTS, LP | 02/14/2025 | 11.76 M | $18.59 M | 100.00% | 30.24% |
| BVF INC/IL | 02/14/2025 | 9.24 M | $14.60 M | 100.00% | 23.74% |
| REDMILE GROUP, LLC | 02/14/2025 | 6.48 M | $10.23 M | 1,183.43% | 16.64% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 6.01 M | $9.50 M | 100.00% | 15.45% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 5.88 M | $9.29 M | 100.00% | 15.11% |
| FMR LLC | 02/13/2025 | 5.23 M | $8.27 M | -0.05% | 13.45% |
| VANGUARD GROUP INC | 02/11/2025 | 2.94 M | $4.65 M | -6.80% | 7.56% |
| BLACKROCK, INC. | 02/07/2025 | 2.30 M | $3.63 M | -8.00% | 5.91% |
| COLUMN GROUP LLC | 02/14/2025 | 1.33 M | $2.10 M | -50.44% | 3.42% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.24 M | $1.96 M | 100.00% | 3.20% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 1.17 M | $1.86 M | 15,557.51% | 3.02% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 1.00 M | $1.58 M | 100.00% | 2.57% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 862,886 | $1.36 M | 2.46% | 2.22% |
| FEDERATED HERMES, INC. | 02/13/2025 | 802,618 | $1.27 M | 0.33% | 2.06% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 770,013 | $1.22 M | -26.54% | 1.98% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 737,704 | $1.17 M | -23.15% | 1.90% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 716,937 | $1.13 M | 4.94% | 1.84% |
| STATE STREET CORP | 02/14/2025 | 699,245 | $1.10 M | 2.90% | 1.80% |
| EUCLIDEAN CAPITAL LLC | 02/14/2025 | 657,899 | $1.04 M | 0.00% | 1.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 02/14/2025 | 575,000 | $908,500 | -66.67% | 1.48% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 503,700 | $795,846 | -28.55% | 1.29% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 486,948 | $769,378 | 22.42% | 1.25% |
| MORGAN STANLEY | 02/14/2025 | 435,835 | $688,620 | 41.86% | 1.12% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 369,736 | $584,183 | 25.50% | 0.95% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 300,079 | $474,124 | 0.18% | 0.77% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 276,170 | $436,349 | -3.25% | 0.71% |
| NORTHERN TRUST CORP | 02/14/2025 | 245,599 | $388,047 | 1.28% | 0.63% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 219,997 | $347,595 | 9.21% | 0.57% |
| JPMORGAN CHASE & CO | 02/12/2025 | 205,164 | $324,158 | 1,128.31% | 0.53% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 200,000 | $316,000 | -59.74% | 0.51% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 180,465 | $285,135 | -65.32% | 0.46% |
| UBS GROUP AG | 02/14/2025 | 149,669 | $236,477 | 418.86% | 0.38% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 148,823 | $235,233 | -41.42% | 0.38% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 125,000 | $197,500 | 66.67% | 0.32% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 125,000 | $197,500 | 100.00% | 0.32% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 116,925 | $184,741 | 50.47% | 0.30% |
| AJU IB INVESTMENT CO., LTD. | 04/08/2025 | 99,503 | $157,215 | 100.00% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 90,144 | $142,428 | -0.07% | 0.23% |
| EXCHANGE TRADED CONCEPTS, LLC | 01/21/2025 | 89,076 | $140,740 | 0.00% | 0.23% |
| TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 02/14/2025 | 73,383 | $115,945 | 100.00% | 0.19% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 70,979 | $112,147 | 0.05% | 0.18% |
| HAP TRADING, LLC | 02/13/2025 | 62,500 | $26,563 | 100.00% | 0.16% |
| CITADEL ADVISORS LLC | 02/14/2025 | 58,500 | $92,430 | 128.52% | 0.15% |
| COMERICA BANK | 02/14/2025 | 58,040 | $91,703 | 100.00% | 0.15% |
| CALLAN FAMILY OFFICE, LLC | 02/07/2025 | 58,040 | $91,703 | 100.00% | 0.15% |
| CITADEL ADVISORS LLC | 02/14/2025 | 55,100 | $87,058 | 2,195.83% | 0.14% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
RAPT Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 132 institutional investors and hedge funds held shares of RAPT Therapeutics, Inc.. The most heavily invested institutionals were:
MASSMUTUAL TRUST CO FSB/ADV: 0
ORBIMED ADVISORS LLC: 13.14 M
TCG Crossover Management, LLC: 13.14 M
Foresite Capital Management VI LLC: 12.5 M
RTW INVESTMENTS, LP: 11.76 M
BVF INC/IL: 9.24 M
326.17% of RAPT Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 115.13 M shares in the last 24 months. This purchase volume represents approximately $99.41 M in transactions.